ReShape Lifesciences Announces 1-For-58 Reverse Stock Split, Effective September 23, 2024
Portfolio Pulse from Benzinga Newsdesk
ReShape Lifesciences has announced a 1-for-58 reverse stock split effective September 23, 2024. This will include proportional adjustments to warrants, stock options, and convertible preferred stock.
September 19, 2024 | 12:34 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
ReShape Lifesciences is implementing a 1-for-58 reverse stock split, which will affect its stock price and related financial instruments like warrants and stock options.
The reverse stock split will consolidate shares, potentially increasing the stock price per share but reducing the number of shares outstanding. This action is often taken to meet exchange listing requirements or to improve the perception of the stock. The proportional adjustments to warrants, stock options, and convertible preferred stock ensure that these instruments remain equitable post-split.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100